BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23426428)

  • 1. Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin.
    Cowans NJ; Suonpaa M; Kouru H; Wright D; Spencer K
    Clin Chem; 2013 Jun; 59(6):968-75. PubMed ID: 23426428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting.
    Browne JL; Schielen PC; Belmouden I; Pennings JL; Klipstein-Grobusch K
    Prenat Diagn; 2015 Jun; 35(6):592-7. PubMed ID: 25688936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting.
    Pennings JL; Siljee JE; Imholz S; Kuc S; de Vries A; Schielen PC; Rodenburg W
    Dis Markers; 2014; 2014():509821. PubMed ID: 25132703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers.
    Spencer K; Cowans NJ
    Prenat Diagn; 2013 Feb; 33(2):124-9. PubMed ID: 23172596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage.
    Spencer K; Cowans NJ
    Prenat Diagn; 2013 Feb; 33(2):116-23. PubMed ID: 23169109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological variation of free β chorionic gonadotropin and pregnancy-associated plasma protein A in first trimester pregnancies.
    Sennels HP; Jørgensen FS; Sørensen S
    Clin Chem Lab Med; 2011 Feb; 49(2):291-5. PubMed ID: 21091265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
    Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP-A immunofluorometric assay.
    Krantz D; Hallahan T; Ravens R; He K; Cuckle H; Sherwin J; Carmichael J
    Prenat Diagn; 2011 Sep; 31(9):869-74. PubMed ID: 21692092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester screening for aneuploidy: serum biochemical markers.
    Canick JA; Kellner LH
    Semin Perinatol; 1999 Oct; 23(5):359-68. PubMed ID: 10551789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocorrelation and cross-correlation between hCGβ and PAPP-A in repeated sampling during first trimester of pregnancy.
    Nørgaard P; Wright D; Ball S; Newell P; Kirkegaard I; Petersen OB; Uldbjerg N; Tørring N; Jørgensen FS; Friis-Hansen L; Ekelund C; Tabor A; Sørensen S
    Clin Chem Lab Med; 2013 Sep; 51(9):1781-8. PubMed ID: 23612665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical stability of maternal serum markers hCGβ and PAPP-A.
    Veyrat B; Tosetti F; Morin JF; Moineau MP; Piedimonte A; Clément P; Dreux S; Muller F
    Ann Biol Clin (Paris); 2017 Apr; 75(2):158-166. PubMed ID: 28377328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of blood collection method on first-trimester dried blood free Beta hCG and PAPP-A.
    Krantz DA; Carmichael JB
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):611-2. PubMed ID: 23921168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spots.
    Cowans NJ; Stamatopoulou A; Liitti P; Suonpaa M; Spencer K
    Prenat Diagn; 2011 Mar; 31(3):293-8. PubMed ID: 21294137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
    Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
    Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY; Lee CP; Leung KY; Lau E; Tang MH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.